NCT05668351View on ClinicalTrials.gov

Stereotactic Ablative Radiation Therapy for Prostate Cancer

NARecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

May 12, 2023

Primary Completion Date

January 15, 2028

Study Completion Date

January 15, 2028

Conditions
Prostate Cancer
Interventions
RADIATION

SUPR-SABR treatment

SUPR-SABR prescription dose to the PTV\_4000 will be 8 Gy per fraction for five fractions. The prescription dose to PTV\_3625 will be a minimum of 7.25 Gy per fraction for five fractions. SABR will be delivered 2-3 times a week, every other day. There will be a minimum of 40 hours between fractions and maximum of 128 hours between fractions.

Trial Locations (1)

29425

RECRUITING

Medical University of South Carolina Hollings Cancer Center, Charleston

All Listed Sponsors
lead

Medical University of South Carolina

OTHER